SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG
Product details
Registration number: SIN14431P
Classification: Prescription Only
Active ingredients: Glycopyrronium Bromide 63mcg eqv Glycopyrronium
Strength: 50 mcg
Dosage form: CAPSULE
Route: BUCCAL
Registrant: NOVARTIS (SINGAPORE) PTE LTD
ATC code: R03BB06
HSA approval date: 8 November 2013
Manufacturer(s):
- Novartis Pharma Schweizerhalle AG (blending, co-micronisation & postmicronisation of intermediate)
- Siegfried Barbera, S.L
- Novartis Pharma Stein AG (Blending and co-micronization)
Manufacturing country/countries: SWITZERLAND; SPAIN
What are the HSA registration number and classification for SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14431P
Classification: Prescription Only
What active ingredients and strength are recorded for SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Glycopyrronium Bromide 63mcg eqv Glycopyrronium
Strength: 50 mcg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: BUCCAL
Who is the recorded registrant for SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG?
According to the HSA dataset updated 7 August 2026:
Registrant: NOVARTIS (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Novartis Pharma Schweizerhalle AG (blending, co-micronisation & postmicronisation of intermediate)
- Siegfried Barbera, S.L
- Novartis Pharma Stein AG (Blending and co-micronization)
Manufacturing country/countries: SWITZERLAND; SPAIN
Where can I look up SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14431P or the exact product name SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG. The general register link does not preselect this product.
What are the source dates for this SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this SEEBRI BREEZHALER INHALATION POWDER, HARD CAPSULE 50MCG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14431P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)